193 related articles for article (PubMed ID: 31850970)
21. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
22. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
23. Update of advanced cutaneous squamous cell carcinoma.
de Jong E; Lammerts MUPA; Genders RE; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1(Suppl 1):6-10. PubMed ID: 34855246
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
25. Advances in cutaneous squamous cell carcinoma.
Winge MCG; Kellman LN; Guo K; Tang JY; Swetter SM; Aasi SZ; Sarin KY; Chang ALS; Khavari PA
Nat Rev Cancer; 2023 Jul; 23(7):430-449. PubMed ID: 37286893
[TBL] [Abstract][Full Text] [Related]
26. Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.
Luo Q; Li W; Zhao T; Tian X; Liu Y; Zhang X
Arch Biochem Biophys; 2015 Oct; 583():47-54. PubMed ID: 26253263
[TBL] [Abstract][Full Text] [Related]
27. A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.
Hassan S; Purdie KJ; Wang J; Harwood CA; Proby CM; Pourreyron C; Mladkova N; Nagano A; Dhayade S; Athineos D; Caley M; Mannella V; Blyth K; Inman GJ; Leigh IM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336867
[TBL] [Abstract][Full Text] [Related]
28. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
29. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
30. Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation.
Conley J; Perry JR; Ashford B; Ranson M
Exp Dermatol; 2024 Apr; 33(4):e15089. PubMed ID: 38659312
[TBL] [Abstract][Full Text] [Related]
31. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
[TBL] [Abstract][Full Text] [Related]
32. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
[TBL] [Abstract][Full Text] [Related]
33. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation.
Zhang L; Shan X; Chen Q; Xu D; Fan X; Yu M; Yan Q; Liu J
J Cell Physiol; 2019 Dec; 234(12):22207-22219. PubMed ID: 31192452
[TBL] [Abstract][Full Text] [Related]
35. Mutational landscape of aggressive cutaneous squamous cell carcinoma.
Pickering CR; Zhou JH; Lee JJ; Drummond JA; Peng SA; Saade RE; Tsai KY; Curry JL; Tetzlaff MT; Lai SY; Yu J; Muzny DM; Doddapaneni H; Shinbrot E; Covington KR; Zhang J; Seth S; Caulin C; Clayman GL; El-Naggar AK; Gibbs RA; Weber RS; Myers JN; Wheeler DA; Frederick MJ
Clin Cancer Res; 2014 Dec; 20(24):6582-92. PubMed ID: 25303977
[TBL] [Abstract][Full Text] [Related]
36. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
Lambert SR; Harwood CA; Purdie KJ; Gulati A; Matin RN; Romanowska M; Cerio R; Kelsell DP; Leigh IM; Proby CM
Int J Cancer; 2012 Aug; 131(3):E216-26. PubMed ID: 22052591
[TBL] [Abstract][Full Text] [Related]
37. Identification of Metastasis-Associated Genes in Cutaneous Squamous Cell Carcinoma Based on Bioinformatics Analysis and Experimental Validation.
Chen L; Liao X; Jiang X; Yan J; Liang J; Hongwei L
Adv Ther; 2022 Oct; 39(10):4594-4612. PubMed ID: 35947350
[TBL] [Abstract][Full Text] [Related]
38. The genetics of cutaneous squamous cell carcinogenesis.
Campos MA; Lopes JM; Soares P
Eur J Dermatol; 2018 Oct; 28(5):597-605. PubMed ID: 30530431
[TBL] [Abstract][Full Text] [Related]
39. Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event?
Nelson TG; Ashton RE
J Surg Oncol; 2017 Nov; 116(6):783-788. PubMed ID: 28703911
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]